Ovid Therapeutics Inc (NQ: OVID )

3.670 USD -0.030 (-0.81%)

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 4, 2021 Add to My Watchlist

Price and Volume

Volume	241,845
Open	3.730
Bid (Size)	3.570 (50)
Ask (Size)	3.790 (2)
Prev. Close	3.700
Today's Range	3.640 - 3.790
52wk Range	2.250 - 8.370
Shares Outstanding	67,807,266
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Ovid Therapeutics Strengthens Board & Leadership Team to Focus Efforts on Expanding Its Neurosciences Capabilities

July 08, 2021

Ovid Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference

July 07, 2021

Performance

YTD	+51.03%	+51.03%
1 Month	-8.82%	-8.82%
3 Month	+4.26%	+4.26%
6 Month	+11.55%	+11.55%
1 Year	-46.42%	-46.42%

More News

Ovid Therapeutics Appoints Jeff Rona as Chief Business and Financial Officer

June 04, 2021

Ovid Therapeutics Appoints Dr. Joy A. Cavagnaro and Dr. Bruce A. Sullenger to its Scientific Advisory Board

May 26, 2021

Ovid Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update

May 13, 2021

Ovid Therapeutics to Participate in the 2021 RBC Capital Markets Global Healthcare Conference

May 12, 2021

Ovid Therapeutics Announces Appointment of Professor Robert S. Langer, Sc.D., as Chair of its Scientific Advisory Board

April 20, 2021

OVID Provides Update on OV101 Program and the Prioritization of its Resources

April 19, 2021

Ovid Therapeutics Announces Closing of Agreement with Takeda for Global Development and Commercialization of Soticlestat

March 30, 2021

Ovid Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results, Provides Corporate Update for 2021

March 15, 2021

First Week of OVID January 2022 Options Trading

July 07, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.